annual CFF:
$214.45M+$50.91M(+31.13%)Summary
- As of today (July 27, 2025), COGT annual cash flow from financing activities is $214.45 million, with the most recent change of +$50.91 million (+31.13%) on December 31, 2024.
- During the last 3 years, COGT annual CFF has risen by +$176.47 million (+464.70%).
- COGT annual CFF is now -7.64% below its all-time high of $232.20 million, reached on December 31, 2020.
Performance
COGT Cash from financing Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
quarterly CFF:
$24.97M+$24.94M(+95938.46%)Summary
- As of today (July 27, 2025), COGT quarterly cash flow from financing activities is $24.97 million, with the most recent change of +$24.94 million (+95938.46%) on March 31, 2025.
- Over the past year, COGT quarterly CFF has dropped by -$189.09 million (-88.33%).
- COGT quarterly CFF is now -88.33% below its all-time high of $214.06 million, reached on March 31, 2024.
Performance
COGT quarterly CFF Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
TTM CFF:
$25.36M-$189.09M(-88.17%)Summary
- As of today (July 27, 2025), COGT TTM cash flow from financing activities is $25.36 million, with the most recent change of -$189.09 million (-88.17%) on March 31, 2025.
- Over the past year, COGT TTM CFF has dropped by -$351.78 million (-93.27%).
- COGT TTM CFF is now -93.27% below its all-time high of $377.15 million, reached on March 31, 2024.
Performance
COGT TTM CFF Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Cash from financing Formula
CFF = Cash Inflows from Financing Activities − Cash Outflows from Financing Activities
COGT Cash from financing Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +31.1% | -88.3% | -93.3% |
| 3 y3 years | +464.7% | +10000.0% | -33.6% |
| 5 y5 years | +10000.0% | +10000.0% | +10000.0% |
COGT Cash from financing Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | at high | +464.7% | -88.3% | +9853.9% | -93.3% | at low |
| 5 y | 5-year | -7.6% | >+9999.0% | -88.3% | +9853.9% | -93.3% | >+9999.0% |
| alltime | all time | -7.6% | >+9999.0% | -88.3% | +3501.9% | -93.3% | +2106.7% |
COGT Cash from financing History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2025 | - | $24.97M(>+9900.0%) | $25.36M(-88.2%) |
| Dec 2024 | $214.45M(+31.1%) | $26.00K(-95.8%) | $214.45M(+0.0%) |
| Sep 2024 | - | $624.00K(-343.8%) | $214.43M(-0.2%) |
| Jun 2024 | - | -$256.00K(-100.1%) | $214.80M(-43.0%) |
| Mar 2024 | - | $214.06M(>+9900.0%) | $377.15M(+130.6%) |
| Dec 2023 | $163.54M(-0.0%) | $0.00(-100.0%) | $163.54M(-0.2%) |
| Sep 2023 | - | $1.00M(-99.4%) | $163.85M(+0.0%) |
| Jun 2023 | - | $162.09M(>+9900.0%) | $163.84M(-0.0%) |
| Mar 2023 | - | $445.00K(+41.3%) | $163.87M(+0.2%) |
| Dec 2022 | $163.56M(+330.7%) | $315.00K(-68.2%) | $163.56M(-18.7%) |
| Sep 2022 | - | $990.00K(-99.4%) | $201.25M(+0.5%) |
| Jun 2022 | - | $162.12M(>+9900.0%) | $200.31M(+424.4%) |
| Mar 2022 | - | $138.00K(-99.6%) | $38.20M(+0.6%) |
| Dec 2021 | $37.98M(-83.6%) | $38.01M(>+9900.0%) | $37.98M(-68.9%) |
| Sep 2021 | - | $55.00K(>+9900.0%) | $122.11M(-47.4%) |
| Jun 2021 | - | $0.00(-100.0%) | $231.98M(-0.0%) |
| Mar 2021 | - | -$85.00K(-100.1%) | $232.04M(-0.1%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Dec 2020 | $232.20M(>+9900.0%) | $122.14M(+11.1%) | $232.20M(+111.0%) |
| Sep 2020 | - | $109.92M(>+9900.0%) | $110.06M(>+9900.0%) |
| Jun 2020 | - | $62.00K(-15.1%) | $135.00K(-20.6%) |
| Mar 2020 | - | $73.00K(>+9900.0%) | $170.00K(+57.4%) |
| Dec 2019 | $108.00K(-99.8%) | $0.00(0.0%) | $108.00K(-78.5%) |
| Sep 2019 | - | $0.00(-100.0%) | $503.00K(-25.8%) |
| Jun 2019 | - | $97.00K(+781.8%) | $678.00K(-99.0%) |
| Mar 2019 | - | $11.00K(-97.2%) | $70.89M(+0.8%) |
| Dec 2018 | $70.35M(-9749.7%) | $395.00K(+125.7%) | $70.35M(+1.6%) |
| Sep 2018 | - | $175.00K(-99.8%) | $69.22M(+0.2%) |
| Jun 2018 | - | $70.31M(<-9900.0%) | $69.05M(-5562.6%) |
| Mar 2018 | - | -$535.00K(-27.1%) | -$1.26M(+73.4%) |
| Dec 2017 | -$729.00K(+1722.5%) | -$734.00K(<-9900.0%) | -$729.00K(<-9900.0%) |
| Sep 2017 | - | $5000.00(>+9900.0%) | $5000.00(>+9900.0%) |
| Jun 2017 | - | $0.00(0.0%) | $0.00(0.0%) |
| Mar 2017 | - | $0.00 | $0.00 |
| Dec 2016 | -$40.00K(-100.1%) | - | - |
| Dec 2015 | $70.75M | - | - |
FAQ
- What is Cogent Biosciences, Inc. annual cash flow from financing activities?
- What is the all time high annual CFF for Cogent Biosciences, Inc.?
- What is Cogent Biosciences, Inc. annual CFF year-on-year change?
- What is Cogent Biosciences, Inc. quarterly cash flow from financing activities?
- What is the all time high quarterly CFF for Cogent Biosciences, Inc.?
- What is Cogent Biosciences, Inc. quarterly CFF year-on-year change?
- What is Cogent Biosciences, Inc. TTM cash flow from financing activities?
- What is the all time high TTM CFF for Cogent Biosciences, Inc.?
- What is Cogent Biosciences, Inc. TTM CFF year-on-year change?
What is Cogent Biosciences, Inc. annual cash flow from financing activities?
The current annual CFF of COGT is $214.45M
What is the all time high annual CFF for Cogent Biosciences, Inc.?
Cogent Biosciences, Inc. all-time high annual cash flow from financing activities is $232.20M
What is Cogent Biosciences, Inc. annual CFF year-on-year change?
Over the past year, COGT annual cash flow from financing activities has changed by +$50.91M (+31.13%)
What is Cogent Biosciences, Inc. quarterly cash flow from financing activities?
The current quarterly CFF of COGT is $24.97M
What is the all time high quarterly CFF for Cogent Biosciences, Inc.?
Cogent Biosciences, Inc. all-time high quarterly cash flow from financing activities is $214.06M
What is Cogent Biosciences, Inc. quarterly CFF year-on-year change?
Over the past year, COGT quarterly cash flow from financing activities has changed by -$189.09M (-88.33%)
What is Cogent Biosciences, Inc. TTM cash flow from financing activities?
The current TTM CFF of COGT is $25.36M
What is the all time high TTM CFF for Cogent Biosciences, Inc.?
Cogent Biosciences, Inc. all-time high TTM cash flow from financing activities is $377.15M
What is Cogent Biosciences, Inc. TTM CFF year-on-year change?
Over the past year, COGT TTM cash flow from financing activities has changed by -$351.78M (-93.27%)